Christopher R. Campos, Ph.D.
Affiliations: | Medical Pharmacology | University of Arizona, Tucson, AZ |
Area:
blood-brain barrier, drug deliveryGoogle:
"Christopher Campos"Mean distance: 18858.7
Parents
Sign in to add mentor| Thomas P. Davis | grad student | 2009 | University of Arizona | |
| (Central regulation of blood-brain barrier integrity during hyperalgesia.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Campos CR, Kemble AM, Niewoehner J, et al. (2020) Brain Shuttle Neprilysin reduces central Amyloid-β levels. Plos One. 15: e0229850 |
| More VR, Campos CR, Evans RA, et al. (2016) PPAR-α, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism |
| Wang X, Campos CR, Peart JC, et al. (2014) Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 8585-93 |
| Bartels K, Ma Q, Venkatraman TN, et al. (2014) Effects of deep hypothermic circulatory arrest on the blood brain barrier in a cardiopulmonary bypass model--a pilot study. Heart, Lung & Circulation. 23: 981-4 |
| Emmert D, Campos CR, Ward D, et al. (2014) Reversible dimers of the atypical antipsychotic quetiapine inhibit p-glycoprotein-mediated efflux in vitro with increased binding affinity and in situ at the blood-brain barrier. Acs Chemical Neuroscience. 5: 305-17 |
| Largent-Milnes TM, Brookshire SW, Skinner DP, et al. (2013) Building a better analgesic: multifunctional compounds that address injury-induced pathology to enhance analgesic efficacy while eliminating unwanted side effects. The Journal of Pharmacology and Experimental Therapeutics. 347: 7-19 |
| Cartwright TA, Campos CR, Cannon RE, et al. (2013) Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 381-8 |
| Durk MR, Chan GN, Campos CR, et al. (2012) 1α,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells. Journal of Neurochemistry. 123: 944-53 |
| Cannon RE, Peart JC, Hawkins BT, et al. (2012) Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. Proceedings of the National Academy of Sciences of the United States of America. 109: 15930-5 |
| Jablonski MR, Jacob DA, Campos C, et al. (2012) Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS. Neurobiology of Disease. 47: 194-200 |